ScholarIQanswers from OpenAlex & ORCID
Peter T. Silberstein
ResearcherPublications, citations & collaboration network
Peter T. Silberstein is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Peter T. Silberstein have?
ScholarIQindexed works
Peter T. Silberstein has 476 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Peter T. Silberstein have?
ScholarIQcitation count
Peter T. Silberstein has 2,678 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Peter T. Silberstein?
ScholarIQh-index
Peter T. Silberstein has an h-index of 26 in OpenAlex.
What is the i10-index of Peter T. Silberstein?
ScholarIQi10-index
Peter T. Silberstein has an i10-index of 54 in OpenAlex.
What is the OpenAlex record for Peter T. Silberstein?
ScholarIQopenalex
The OpenAlex for Peter T. Silberstein is on the source record.
What are the most-cited papers on Peter T. Silberstein?
ScholarIQmost cited works
Phase III, Randomized, Double-Blind Study of Epoetin Alfa Compared With Placebo in Anemic Patients Receiving Chemotherapy
Thomas E. Witzig, Peter T. Silberstein, Charles L. Loprinzi, Jeff A. Sloan, Paul J. Novotny, James A. Mailliard, Kendrith M. Rowland, Steven R. Alberts, James E. Krook, Ralph Levitt, Roscoe F. Morton
Intravenous Calcium and Magnesium for Oxaliplatin-Induced Sensory Neurotoxicity in Adjuvant Colon Cancer: NCCTG N04C7
Axel Grothey, Daniel A. Nikcevich, Jeff A. Sloan, John W. Kugler, Peter T. Silberstein, Todor Dentchev, Donald B. Wender, Paul J. Novotny, Umesh Chitaley, Steven R. Alberts, Charles L. Loprinzi
Controlled‐release oxycodone compared with controlled‐release morphine in the treatment of cancer pain: A randomized, double‐blind, parallel‐group study
Patricia Mucci‐LoRusso, Barry S. Berman, Peter T. Silberstein, Marc L. Citron, Linda R. Bressler, Sharon M. Weinstein, Robert F. Kaiko, Barbara J. Buckley, Robert F. Reder
Phase III, Randomized, Double-Blind, Placebo-Controlled Study of Long-Acting Methylphenidate for Cancer-Related Fatigue: North Central Cancer Treatment Group NCCTG-N05C7 Trial
Amanda R. Moraska, Amit Sood, Shaker R. Dakhil, Jeff A. Sloan, Debra L. Barton, Pamela J. Atherton, Jason Suh, Patricia Griffin, David Johnson, Aneela Ali, Peter T. Silberstein, Steven F. Duane, Charles L. Loprinzi
Epidemiology of Thyroid Cancer: A Review of the National Cancer Database, 2000-2013
Evan Olson, Grant Wintheiser, Katrina M Wolfe, Jonathan Droessler, Peter T. Silberstein